The differential response of glioma stem cells to SHH ligand, as compared to non-stem glioblastoma cells, highlights the potential of SHH pathway-targeted approaches as an effective single-cell killing strategy specifically against the stem-like tumor subpopulation31. The gene discussed is SHH; the disease is glioma.